180 related articles for article (PubMed ID: 34593614)
1. Impact of smoking on the development of idiopathic pulmonary fibrosis: results from a nationwide population-based cohort study.
Bae W; Lee CH; Lee J; Kim YW; Han K; Choi SM
Thorax; 2022 May; 77(5):470-476. PubMed ID: 34593614
[TBL] [Abstract][Full Text] [Related]
2. Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study.
Yoon HY; Kim H; Bae Y; Song JW
Respir Res; 2024 Apr; 25(1):191. PubMed ID: 38685071
[TBL] [Abstract][Full Text] [Related]
3. Tobacco Smoking and Risk for Pulmonary Fibrosis: A Prospective Cohort Study From the UK Biobank.
Bellou V; Belbasis L; Evangelou E
Chest; 2021 Sep; 160(3):983-993. PubMed ID: 33905677
[TBL] [Abstract][Full Text] [Related]
4. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU
Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.
Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW
Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350
[TBL] [Abstract][Full Text] [Related]
6. Risk of cancer incidence in patients with idiopathic pulmonary fibrosis: A nationwide cohort study.
Lee HY; Lee J; Lee CH; Han K; Choi SM
Respirology; 2021 Feb; 26(2):180-187. PubMed ID: 33145926
[TBL] [Abstract][Full Text] [Related]
7. Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study.
Ozaltin B; Chapman R; Arfeen MQU; Fitzpatick N; Hemingway H; Direk K; Jacob J
Respir Res; 2024 Jun; 25(1):249. PubMed ID: 38898447
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.
Harari S; Davì M; Biffi A; Caminati A; Ghirardini A; Lovato V; Cricelli C; Lapi F
Intern Emerg Med; 2020 Apr; 15(3):437-445. PubMed ID: 31541394
[TBL] [Abstract][Full Text] [Related]
9. Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis.
Kärkkäinen M; Kettunen HP; Nurmi H; Selander T; Purokivi M; Kaarteenaho R
Respir Res; 2017 Aug; 18(1):160. PubMed ID: 28830514
[TBL] [Abstract][Full Text] [Related]
10. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis.
García-Sancho C; Buendía-Roldán I; Fernández-Plata MR; Navarro C; Pérez-Padilla R; Vargas MH; Loyd JE; Selman M
Respir Med; 2011 Dec; 105(12):1902-7. PubMed ID: 21917441
[TBL] [Abstract][Full Text] [Related]
11. Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysis.
Kim WY; Mok Y; Kim GW; Baek SJ; Yun YD; Jee SH; Kim DS
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):289-96. PubMed ID: 25591140
[TBL] [Abstract][Full Text] [Related]
12. Association between the use of statins and risk of interstitial lung disease/idiopathic pulmonary fibrosis: time-dependent analysis of population-based nationwide data.
Jang HJ; Lee DY; Loloci G; Jeong J; Choi WI
Eur Respir J; 2023 Jul; 62(1):. PubMed ID: 37202155
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in patients with idiopathic pulmonary fibrosis, based on nationwide claim data.
Lee JH; Lee HH; Park HJ; Kim S; Kim YJ; Lee JS; Kim HC
Ther Adv Respir Dis; 2023; 17():17534666231155772. PubMed ID: 36846942
[TBL] [Abstract][Full Text] [Related]
14. Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.
Abramson MJ; Murambadoro T; Alif SM; Benke GP; Dharmage SC; Glaspole I; Hopkins P; Hoy RF; Klebe S; Moodley Y; Rawson S; Reynolds PN; Wolfe R; Corte TJ; Walters EH;
Thorax; 2020 Oct; 75(10):864-869. PubMed ID: 32660982
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of idiopathic pulmonary fibrosis in inflammatory bowel disease: A nationwide study.
Kim J; Chun J; Lee C; Han K; Choi S; Lee J; Soh H; Choi K; Park S; Kang EA; Lee HJ; Im JP; Kim JS
J Gastroenterol Hepatol; 2020 Feb; 35(2):249-255. PubMed ID: 31420894
[TBL] [Abstract][Full Text] [Related]
16. Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis.
Kärkkäinen M; Nurmi H; Kettunen HP; Selander T; Purokivi M; Kaarteenaho R
BMC Pulm Med; 2018 May; 18(1):69. PubMed ID: 29751748
[TBL] [Abstract][Full Text] [Related]
17. Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis.
Kaunisto J; Kelloniemi K; Sutinen E; Hodgson U; Piilonen A; Kaarteenaho R; Mäkitaro R; Purokivi M; Lappi-Blanco E; Saarelainen S; Kankaanranta H; Mursu A; Kanervisto M; Salomaa ER; Myllärniemi M
BMC Pulm Med; 2015 Aug; 15():92. PubMed ID: 26285574
[TBL] [Abstract][Full Text] [Related]
18. Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis.
Teague TT; Payne SR; Kelly BT; Dempsey TM; McCoy RG; Sangaralingham LR; Limper AH
Respir Res; 2022 Apr; 23(1):91. PubMed ID: 35410255
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.
Lee HE; Myong JP; Kim HR; Rhee CK; Yoon HK; Koo JW
Int J Tuberc Lung Dis; 2016 Jul; 20(7):978-84. PubMed ID: 27287654
[TBL] [Abstract][Full Text] [Related]
20. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
